Broadwood Partners, L.P.
SEC-identified person · CIK 1278386 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Oncocyte Corp OCX | Officer | filed 2016 - 2026 |
| Staar Surgical CO STAA | Director | filed 2007 - 2026 |
| Lineage Cell Therapeutics, Inc. LCTX | Director | filed 2006 - 2025 |
| Asterias Biotherapeutics, Inc. ASTY | Officer | filed 2014 - 2019 |
| Comarco INC cmro | Officer | filed 2007 - 2017 |
| Questcor Pharmaceuticals INC QSC | Director | filed 2013 - 2014 |
| Palomar Medical Technologies LLC PMTI | Officer | filed 2011 - 2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.